These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34339745)

  • 1. Scleroderma renal crisis following mRNA vaccination against SARS-CoV-2.
    Oniszczuk J; Pagot E; Limal N; Hüe S; Audard V; Moktefi A; El Karoui K
    Kidney Int; 2021 Oct; 100(4):940-941. PubMed ID: 34339745
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Series of Patients With Myocarditis Following SARS-CoV-2 Vaccination With mRNA-1279 and BNT162b2.
    Dickey JB; Albert E; Badr M; Laraja KM; Sena LM; Gerson DS; Saucedo JE; Qureshi W; Aurigemma GP
    JACC Cardiovasc Imaging; 2021 Sep; 14(9):1862-1863. PubMed ID: 34246585
    [No Abstract]   [Full Text] [Related]  

  • 4. Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination - a case report.
    Paul G; Chad R
    BMC Pediatr; 2021 Mar; 21(1):138. PubMed ID: 33752624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
    Costa Frossard-França L; García-Domínguez JM; Moreno-Torres I; Fortún J; Villar LM; Meca-Lallana V
    Rev Neurol; 2021 Apr; 72(7):250-260. PubMed ID: 33764494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study.
    Lesny P; Anderson M; Cloherty G; Stec M; Haase-Fielitz A; Haarhaus M; Santos C; Lucas C; Macario F; Haase M
    J Nephrol; 2021 Aug; 34(4):975-983. PubMed ID: 34050904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies.
    Re D; Barrière J; Chamorey E; Delforge M; Gastaud L; Petit E; Chaminade A; Verrière B; Peyrade F
    Leuk Lymphoma; 2021 Dec; 62(13):3308-3310. PubMed ID: 34308748
    [No Abstract]   [Full Text] [Related]  

  • 8. Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms.
    Billany RE; Selvaskandan H; Adenwalla SF; Hull KL; March DS; Burton JO; Bishop NC; Carr EJ; Beale R; Tang JW; Bird PW; Holmes CW; Baines R; Brunskill NJ; Graham-Brown MPM
    Kidney Int; 2021 Jun; 99(6):1492-1494. PubMed ID: 33887316
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistent myopericarditis after heterologous SARS-CoV-2 mRNA vaccination.
    Wu KY; Butler CR; Koshman S; Oudit GY; Ian Paterson D
    CMAJ; 2023 Apr; 195(16):E584-E587. PubMed ID: 37094872
    [No Abstract]   [Full Text] [Related]  

  • 10. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series.
    Danese E; Montagnana M; Salvagno GL; Peserico D; Pighi L; De Nitto S; Henry BM; Porru S; Lippi G
    Clin Chem Lab Med; 2021 Aug; 59(9):1585-1591. PubMed ID: 33838087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
    Trougakos IP; Terpos E; Zirou C; Sklirou AD; Apostolakou F; Gumeni S; Charitaki I; Papanagnou ED; Bagratuni T; Liacos CI; Scorilas A; Korompoki E; Papassotiriou I; Kastritis E; Dimopoulos MA
    BMC Med; 2021 Aug; 19(1):208. PubMed ID: 34420521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection.
    Simon HU; Karaulov AV; Bachmann MF
    Int Arch Allergy Immunol; 2020; 181(8):624-628. PubMed ID: 32544911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won.
    Torreggiani M; Blanchi S; Fois A; Fessi H; Piccoli GB
    Kidney Int; 2021 Jun; 99(6):1494-1496. PubMed ID: 33887320
    [No Abstract]   [Full Text] [Related]  

  • 14. Single Dose of an mRNA Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) Vaccine Is Associated With Lower Nasopharyngeal Viral Load Among Nursing Home Residents With Asymptomatic Coronavirus Disease 2019 (COVID-19).
    McEllistrem MC; Clancy CJ; Buehrle DJ; Lucas A; Decker BK
    Clin Infect Dis; 2021 Sep; 73(6):e1365-e1367. PubMed ID: 33768222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiform Erythema After COVID-19 mRNA Vaccination.
    Majenka P; Naoum C; Hartmann M
    Dtsch Arztebl Int; 2021 Oct; 118(41):690. PubMed ID: 34951399
    [No Abstract]   [Full Text] [Related]  

  • 16. Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination.
    Kim N; Minn D; Park S; Roh EY; Yoon JH; Park H; Shin S
    J Korean Med Sci; 2021 May; 36(21):e158. PubMed ID: 34060264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer.
    Mueller T
    Clin Chim Acta; 2021 Jul; 518():9-16. PubMed ID: 33741357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis.
    Espi M; Charmetant X; Barba T; Koppe L; Pelletier C; Kalbacher E; Chalencon E; Mathias V; Ovize A; Cart-Tanneur E; Bouz C; Pellegrina L; Morelon E; Fouque D; Juillard L; Thaunat O
    Kidney Int; 2021 Oct; 100(4):928-936. PubMed ID: 34284044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.
    Salvagno GL; Henry BM; Pighi L; De Nitto S; Gianfilippi GL; Lippi G
    J Infect; 2021 Aug; 83(2):e4-e5. PubMed ID: 34214516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.